BBOT vs WMB · rev $7.5M vs P/E 31, rev $6.08B
BridgeBio Oncology Therapeutics, Inc. (BBOT) versus Williams Companies Inc (WMB) — a side-by-side from cached financials, not a winner call.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
Williams Companies Inc (WMB) is a oil & gas midstream company listed on NYSE.
Latest reported BBOT revenue for 2026-06-30 was $7.5M. Net income was -$98.6M. Revenue was up 90.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.
Latest reported WMB revenue for 2026-06-30 was $6.08B. Net income was $1.69B. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
BBOT currently screens at market cap $610.4M. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
Not investment advice. Open the BBOT and WMB stock pages for the full models.
Not investment advice.